Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
TCS IN THE NEWS
You have these already downloaded
We have sent you a copy of the report to your email again.
By Debashis Ghosh, TCS in the International Clinical Trials Magazine
As life sciences firms increasingly look to BRIC countries for strategic growth, a granular assessment of the drivers and constraints in each market – including revenue, savings and innovation potential – is needed to support the business case.
In this article, Debashis Ghosh discusses how TCS’ Emerging Markets Index (EMI) model helps life sciences firms assess the viability of doing business in emerging markets like the BRIC countries. The EMI examines three complementary yet distinct perspectives – revenue, savings and innovation. Using this model, companies can understand the opportunities, challenges and risks in each of these markets and make more informed decisions.